CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)-Reference-Cited by-同舟云学术

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)

Published:2002-06 Issue:5 Volume:1 Page:421-432
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Kelly Louise M,Yu Jin-Chen,Boulton Christina L,Apatira Mutiah,Li Jason,Sullivan Carol M,Williams Ifor,Amaral Sonia M,Curley David P,Duclos Nicole,Neuberg Donna,Scarborough Robert M,Pandey Anjali,Hollenbach Stanley,Abe Keith,Lokker Nathalie A,Gilliland D.Gary,Giese Neill A

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference52 articles.

1. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group;Abu-Duhier;Br. J. Haematol.,2000

2. Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia;Abu-Duhier;Br. J. Haematol.,2001

3. Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival;Benekli;Blood,2002

4. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148);Beran;Clin. Cancer Res.,1998

5. Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts;Birkenkamp;Leukemia,2001

Cited by 281 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision medicine in AML: overcoming resistance;International Journal of Hematology;2024-08-01

2. A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia;Blood Advances;2024-05-21

3. Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemia;BMC Chemistry;2023-07-12

4. GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS;Mediterranean Journal of Hematology and Infectious Diseases;2023-04-28

5. Design, synthesis, and biological evaluation with molecular dynamics study of novel pyrazolo[3,4-d]pyrimidine derivatives as anti-cancer agents;RSC Advances;2023